(Q44704180)
Statements
1 reference
A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors (English)
1 reference
Richly H
1 reference
Kupsch P
1 reference
Passage K
1 reference
Grubert M
1 reference
Hilger RA
1 reference
Kredtke S
1 reference
Voliotis D
1 reference
Scheulen ME
1 reference
Seeber S
1 reference
Strumberg D
1 reference
1 December 2003
1 reference
1 reference
41
1 reference
12
1 reference
620-621
1 reference
Identifiers
1 reference